| finasteride | R Documentation |
center: Center ID
n1: Number of observations in finasteride group
m1: Mean of the change of Boyarsky score from baseline in finasteride group
s1: SD of the change of Boyarsky score from baseline in finasteride group
n0: Number of observations in placebo group
m0: Mean of the change of Boyarsky score from baseline in placebo group
s0: SD of the change of Boyarsky score from baseline in placebo group
data(PPI)
A data frame with 29 rows and 7 variables
Nakamura, R., and Noma, H. (2021). Detection of outlying centers and influence diagnostics for the analysis of multicenter clinical trials (in Japanese). Japanese Journal of Biometrics. 41(2): 117-136. \Sexpr[results=rd]{tools:::Rd_expr_doi("10.5691/jjb.41.117")}
Gormley, G. J., Stoner, E., Bruskewitz, R. C., et al. (1992). The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. New England Journal of Medicine. 327: 1185-1191. \Sexpr[results=rd]{tools:::Rd_expr_doi("10.1056/nejm199210223271701")}
Gould, A. L. (1998). Multi-centre trial analysis revisited. Statistics in Medicine. 17: 1779-1797.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.